Aurora Cannabis Inc - Asset Resilience Ratio
Aurora Cannabis Inc (ACB) has an Asset Resilience Ratio of 4.95% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Aurora Cannabis Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2009–2026)
This chart shows how Aurora Cannabis Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Aurora Cannabis Inc balance sheet assets.
Liquid Assets Composition Over Time
This chart breaks down Aurora Cannabis Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Aurora Cannabis Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $30.74 Million | 4.95% |
| Total Liquid Assets | $30.74 Million | 4.95% |
Asset Resilience Insights
- Limited Liquidity: Aurora Cannabis Inc maintains only 4.95% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Aurora Cannabis Inc Industry Peers by Asset Resilience Ratio
Compare Aurora Cannabis Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Torrent Pharmaceuticals Limited
NSE:TORNTPHARM |
Drug Manufacturers - Specialty & Generic | 2.79% |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Beijing Tongrentang Co Ltd
SHG:600085 |
Drug Manufacturers - Specialty & Generic | 2.51% |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858 |
Drug Manufacturers - Specialty & Generic | 3.47% |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423 |
Drug Manufacturers - Specialty & Generic | 20.44% |
|
Harbin Pharmaceutical Group Co Ltd
SHG:600664 |
Drug Manufacturers - Specialty & Generic | 0.97% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
Annual Asset Resilience Ratio for Aurora Cannabis Inc (2009–2026)
The table below shows the annual Asset Resilience Ratio data for Aurora Cannabis Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2026-03-31 | 8.69% | $52.35 Million | $602.64 Million | +8.62pp |
| 2025-03-31 | 0.06% | $550.82K | $847.77 Million | -0.42pp |
| 2024-03-31 | 0.48% | $4.04 Million | $840.14 Million | +0.34pp |
| 2022-03-31 | 0.14% | $1.33 Million | $926.38 Million | +0.01pp |
| 2021-03-31 | 0.14% | $3.75 Million | $2.72 Billion | -0.10pp |
| 2020-03-31 | 0.24% | $7.04 Million | $2.92 Billion | -2.31pp |
| 2019-03-31 | 2.55% | $143.80 Million | $5.64 Billion | -0.59pp |
| 2018-03-31 | 3.14% | $59.59 Million | $1.90 Billion | -1.49pp |
| 2017-03-31 | 4.63% | $14.98 Million | $323.82 Million | +4.24pp |
| 2016-03-31 | 0.39% | $71.00K | $18.32 Million | +0.38pp |
| 2015-03-31 | 0.01% | $1.50K | $13.53 Million | -97.50pp |
| 2012-03-31 | 97.51% | $1.13 Million | $1.16 Million | +0.25pp |
| 2011-03-31 | 97.26% | $1.35 Million | $1.39 Million | +8.79pp |
| 2010-03-31 | 88.46% | $1.53 Million | $1.73 Million | -8.62pp |
| 2009-03-31 | 97.09% | $1.58 Million | $1.62 Million | -- |
About Aurora Cannabis Inc
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis… Read more